VISUAL MIDLINE SHIFT SYNDROME

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting VISUAL MIDLINE SHIFT SYNDROME:

# Drug Count
0 AMLODIPINE BESYLATE 1
1 ASPIRIN 1
2 BENZONATATE 1
3 CLOPIDOGREL 1
4 CLOPIDOGREL BISULFATE 1
5 DUPILUMAB 1
6 MIGALASTAT HYDROCHLORIDE 1
7 NITROGLYCERIN 1
8 SILDENAFIL CITRATE 1
9 ZOLPIDEM TARTRATE 1
See all common drugs associated with VISUAL MIDLINE SHIFT SYNDROME

VISUAL MIDLINE SHIFT SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIGALASTAT HYDROCHLORIDE 1 0.0018
1 BENZONATATE 1 0.0001
2 NITROGLYCERIN 1 0.0000
3 CLOPIDOGREL BISULFATE 1 0.0000
4 SILDENAFIL CITRATE 1 0.0000
5 ZOLPIDEM TARTRATE 1 0.0000
6 AMLODIPINE BESYLATE 1 0.0000
7 CLOPIDOGREL 1 0.0000
8 DUPILUMAB 1 0.0000
9 ASPIRIN 1 0.0000
See all drugs enriched for association with VISUAL MIDLINE SHIFT SYNDROME

VISUAL MIDLINE SHIFT SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Non-narcotic Antitussive [EPC] 1 0.0001
1 Nitrate Vasodilator [EPC] 1 0.0000
2 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
3 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
4 Platelet Aggregation Inhibitor [EPC] 1 0.0000
5 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with VISUAL MIDLINE SHIFT SYNDROME